期刊文献+

胃肝样腺癌1例并文献综述 被引量:3

下载PDF
导出
摘要 胃肝样腺癌(hepatoid adenocarcinoma of the stomach, HAS)是具有腺癌和肝细胞癌样分化特征的原发性胃癌。1970年Bourreille[1]报道首例AFP阳性并伴有肝转移的胃癌,1985年Ishikura[2]等报道胃腺癌具有肝细胞癌样分化,血清及肿瘤组织中检测出AFP增高,首次将该病单独提出,诊断为HAS,由于HAS的发病率比较低,至今为止,HAS的病例报道多为个案或者小样本病例报道,此病的临床和病理特点尚未完全被人们所认识。本文就本院收治的1例胃肝样腺癌病例进行分析探讨,旨在加深临床对这一少见病的认识,以提高诊治水平。
出处 《临床普外科电子杂志》 2013年第4期46-47,50,共3页 Journal of General Surgery for Clinicians(Electronic Version)
  • 相关文献

参考文献4

二级参考文献31

  • 1许东辉,江显毅,张思宇,方庆全,陈福真.胃肝样腺癌临床及病理特点[J].中国临床医学,2004,11(3):372-373. 被引量:8
  • 2李汉贤.AFP阳性胃癌的临床特点与治疗[J].实用癌症杂志,1995,10(4):239-242. 被引量:8
  • 3张定芳,肖家诚,金晓龙.胃肝样腺癌的临床与病理关系初步探讨[J].胃肠病学,2006,11(5):273-276. 被引量:11
  • 4杨春康,赵文锦,戴起宝,张惠灏,郑炜.胃肝样腺癌临床特点及诊治分析[J].中华胃肠外科杂志,2007,10(3):245-248. 被引量:9
  • 5刘巍,吴志勇.胃肝样腺癌[J].中华外科杂志,2007,45(15):1069-1071. 被引量:14
  • 6Michaud DS. Epidemiology of pancreatic cancer [ J ]. Minerva Chir, 2004, 59(2):99- 111.
  • 7Schneider G, Siveke JT, Eckel F, et al. Pancreatic cancer: basic and clinical aspects[ J ]. Gastroenterology, 2005, 128 : 1606 - 1625.
  • 8Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J]. N Engl J Med, 2004, 350:1200- 1210.
  • 9Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial [J]. JClin, 1997, 15:2403 -2413.
  • 10Yip D, Karapetis C, Strickland A, et al. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer [ J ]. Cochrane Database Syst Rev, 2006, 3 : a2093.

共引文献65

同被引文献38

  • 1Min-Feng Ye,Feng Tao,Fang Liu,Ai-Jing Sun.Hepatoid adenocarcinoma of the stomach: A report of three cases[J].World Journal of Gastroenterology,2013,19(27):4437-4442. 被引量:9
  • 2张定芳,肖家诚,金晓龙.胃肝样腺癌的临床与病理关系初步探讨[J].胃肠病学,2006,11(5):273-276. 被引量:11
  • 3王孝廉.胃的肝样腺癌[J].山西医药杂志,1987,16(6):330-331,393.
  • 4王燕,谢华红,刘杰.胃肝样腺癌的免疫病理特点分析—附1例病例报告[J].现代肿瘤医学,2007,15(12):1810-1812. 被引量:10
  • 5Baek SK, Han SW, Oh DY, et al. Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare hut unique subtype of gastric cancer[ J]. BMC Gastroenterolo- gy, 2011, 11(1) :56-57.
  • 6Bourreille J, Metayer P, Sauger F, et al. Existence of alphafeto pro- tein during gastric-origin secondary cancer ofthe liver [ J ]. Presse Med, 1970, 78(28) :1277-1278.
  • 7Ishikura H, Fukasawa Y, Ogasawara K, et al. An AFP producing gastric carcinoma with features of hepatic differentiation. A case re- port [J]. Cancer, 1985, 56(4) :840-848.
  • 8Morimoto H, Tanigawa N, Inoue H, et al. Alpha-feto-protein-pro- dueing renal cell carcinoma[ J]. Cancer, 1988, 6(1 ) :84-88.
  • 9Akiyama S, Tamura G, Endoh Y, et al. Histogenesis of hepatoid adenocarcinoma of the stomach : molecular evidence of identical ori- gin with coexistent tubular adenoearcinoma[J].Int J Cancer, 2006, 106(4) :510-515.
  • 10Fujii H, Ichikawa K, Takagaki T, et al. Genetic evolution of ct-feto- protein-producing gastric cancer[ J]. J Clin Pathol, 2003, 56(12) : 942 -949.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部